AN ACT CONCERNING THE SHORTAGE OF CERTAIN DRUGS PRESCRIBED TO TREAT TYPE II DIABETES.
To provide that the Commissioner of Consumer Protection shall adopt regulations to ensure that there is a sufficient supply of dulaglutide and semaglutide to treat patients in this state who have been diagnosed with type II diabetes.
Introduced by:
General Law CommitteeNew today | 2-4 days old | 5 days & older |
Text of Bill | |
File No. 94 [doc] | |
GL Joint Favorable [doc] | |
Committee Bill [doc] | |
Proposed Bill [doc] |
Votes | |
Senate Roll Call Vote 140 |
Add Notes to SB-80
Go To My Bills
This bill is in My Bills.
Do you wish to go to My Bills?
Co-sponsors for Amendment LCO:
Bill History
Date | Action Taken | ||
---|---|---|---|
5/5/2023 | House Calendar Number 489 | ||
5/5/2023 | Favorable Report, Tabled for the Calendar, House | ||
5/4/2023 | Senate Passed | ||
3/16/2023 | (LCO) | File Number 94 | |
3/16/2023 | Senate Calendar Number 84 | ||
3/16/2023 | Favorable Report, Tabled for the Calendar, Senate | ||
3/16/2023 | (LCO) | Reported Out of Legislative Commissioners' Office | |
3/10/2023 | (LCO) | Referred to Office of Legislative Research and Office of Fiscal Analysis 03/15/23 5:00 PM | |
3/3/2023 | (LCO) | Filed with Legislative Commissioners' Office | |
3/2/2023 | (GL) | Joint Favorable | |
2/28/2023 | Referred to Joint Committee on General Law | ||
2/27/2023 | Drafted by Committee | ||
2/16/2023 | (GL) | Vote to Draft | |
2/3/2023 | Public Hearing 02/07 | ||
1/19/2023 | (GL) | Reserved for Subject Matter Public Hearing | |
1/12/2023 | Referred to Joint Committee on General Law |
Co-sponsors of SB-80
NOTE: Please direct all inquiries regarding the status of bills to the Office of the House Clerk and/or Senate Clerks' Office.